J.W. Cole Advisors’s iBio IBIO Stock Holding History

J.W. Cole Advisors’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-52	Closed	-$53K	–	745
2020 Q3	$53K	Buy	+52	New	+$75.4K	﹤0.01%	745

Other funds holding IBIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

J.W. Cole Advisors's IBIO Position: Q4 2020 in Review

J.W. Cole Advisors sold out of iBio (IBIO) in Q4 2020, closing a stake of 52 shares — an estimated $53K sold.

J.W. Cole Advisors first reported a position in IBIO in Q3 2020 and held it in 1 quarter. The position peaked at $53K in Q3 2020. 89 funds tracked by Wall St. Rank hold IBIO as of Q4 2020.

J.W. Cole Advisors reported no remaining iBio position as of Q4 2020 after selling out during the quarter.
J.W. Cole Advisors sold 52 iBio shares in Q4 2020, an estimated $53K.
J.W. Cole Advisors first reported a position in iBio in Q3 2020 and held it in 1 quarter.
J.W. Cole Advisors's iBio position peaked at $53K in Q3 2020.
89 funds tracked by Wall St. Rank held iBio as of Q4 2020.

Based on J.W. Cole Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.